Weight-loss drug users may find themselves having to scale back. Compounding pharmacies had been producing these off-brand versions under special allowances due to shortages of the FDA-approved ...

it opened the door for compounding pharmacies to legally fill the gap and make copies of brand-name medications by altering some ingredients. Generic versions of Ozempic, Wegovy, and Mounjaro ...

70. Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy.

A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's (NOVOb.CO), opens new tab popular diabetes and weight-loss drugs Ozempic and Wegovy while ...

People who’ve been using more affordable copycat versions of Ozempic or Wegovy to lose weight will no longer have that option. “They are generally much more accessible — you can get them ...

FDA was notified by Novo Nordisk on April 3 that several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg were in the ... are di fferent from compounded versions of the drug ...

Semaglutide 1 mg demonstrated statistically significant and superior improvement in maximum walking distance by 13% over placebo in adults with type 2 diabetes and symptomatic PAD 1 Based on ...

followed by restrictions on compounded Ozempic and Wegovy set for later this spring, the agency is meeting resistance from telehealth companies and compounding pharmacies that are continuing to ...

Iuliia Burmistrova/Getty Images The FDA has ordered compounding pharmacies to stop making less expensive versions of popular weight loss medications like Ozempic and Zepbound. The order comes ...

Ozempic and Wegovy, the widely popular forms ... setting off concerted pushback from compounding pharmacy groups that were able to sell copycat versions of the drugs while they were in shortage.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections ...